I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Safety of switching from intravenous to subcutaneous rituxi..:
García-Muñoz, Ricardo
;
Quero, Cristina
;
Pérez-Persona, Ernesto
...
http://hdl.handle.net/10668/14571. , 2019
Link:
http://hdl.handle.net/10668/14571
RT Journal T1
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study
UL https://suche.suub.uni-bremen.de/peid=base-ftsspa:oai:www.repositoriosalud.es:10668_14571&Exemplar=1&LAN=DE A1 García-Muñoz, Ricardo A1 Quero, Cristina A1 Pérez-Persona, Ernesto A1 Domingo-García, Abel A1 Pérez-López, Cristina A1 Villaescusa-de-la-Rosa, Teresa A1 Martínez-Castro, Ana M A1 Arguiñano-Pérez, José M A1 Parra-Cuadrado, Juan F A1 Panizo, Carlos YR 2019 K1 administration-related reactions K1 follicular lymphoma K1 non-Hodgkin diffuse large B-cell lymphoma K1 rituximab K1 safety K1 Administration K1 Intravenous K1 Adolescent K1 Adult K1 Aged K1 80 and over K1 Disease-Free Survival K1 Female K1 Humans K1 Infusions K1 Subcutaneous K1 Lymphoma K1 Large B-Cell K1 Diffuse K1 Male K1 Middle Aged K1 Quality of Life K1 Spain K1 Survival Rate JF http://hdl.handle.net/10668/14571 LK http://hdl.handle.net/10668/14571 DO http://hdl.handle.net/10668/14571 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)